or Try an Advanced Search...

    Hematologic Malignancies Stocks List

    Symbol Grade Name % Change
    TCRX B TScan Therapeutics, Inc. 0.00
    CLLS B Cellectis S.A. 0.00
    PRTC B PureTech Health plc 0.00
    INMB C INmune Bio Inc. 0.00
    SLS C SELLAS Life Sciences Group, Inc. 0.00
    KYMR C Kymera Therapeutics, Inc. 0.00
    HOWL C Werewolf Therapeutics, Inc. 0.00
    INCY D Incyte Corporation 0.00
    AFMD D Affimed Therapeutics B.V. 0.00
    APTO F Aptose Biosciences, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Solid Tumors Biopharmaceutical Cancer Medicine Tumors Of The Hematopoietic And Lymphoid Tissues Acute Myeloid Leukemia Biotechnology Clinical Medicine Immune System Immunology Life Sciences Blastoma CD19 Cancer Treatment Chronic Lymphocytic Leukemia Glioblastoma Health Sciences Immunotherapies Immunotherapy Lymphocytic Leukemia

    Related ETFs - A few ETFs which own one or more of the above listed Hematologic Malignancies stocks.

    Symbol Grade Name Weight
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 7.52
    IDNA C iShares Genomics Immunology and Healthcare ETF 3.54
    FBT D First Trust Amex Biotech Index Fund 3.29
    BIS D ProShares UltraShort Nasdaq Biotechnology 2.09
    XBI D SPDR S&P Biotech ETF 1.89
    View all Hematologic Malignancies ETFs...
    Compare ETFs
    Compare BIS to XBI Compare SURI to BIS Compare SURI to XBI

        Hematologic Malignancies Stocks Recent News

        Date Stock Title
        May 7 PRTC PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
        May 6 APTO Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
        May 6 HOWL The Analyst Verdict: Werewolf Therapeutics In The Eyes Of 4 Experts
        May 5 KYMR Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Released Its First-Quarter Earnings: Here's What Analysts Think
        May 4 INCY Incyte First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 3 KYMR Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript
        May 3 KYMR Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
        May 3 KYMR Wall Street Analysts Predict a 34.41% Upside in Kymera Therapeutics (KYMR): Here's What You Should Know
        May 3 HOWL Werewolf Therapeutics GAAP EPS of -$0.39, revenue of $0.74M
        May 3 HOWL Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
        May 3 KYMR Kymera Therapeutics, Inc. (KYMR) Q1 2024 Earnings Call Transcript
        May 3 KYMR Kymera Therapeutics Inc (KYMR) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
        May 3 INCY Q1 2024 Insight Enterprises Inc Earnings Call
        May 2 CLLS Cellectis announces CFO departure
        May 2 CLLS Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
        May 2 TCRX AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 2 KYMR Kymera Therapeutics GAAP EPS of -$0.69 beats by $0.04, revenue of $10.3M misses by $2.75M
        May 2 KYMR Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update
        May 1 KYMR Kymera Therapeutics Q1 2024 Earnings Preview
        May 1 INCY Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript
        Related Industries: Biotechnology
        Related Stock Lists: Solid Tumors Biopharmaceutical Cancer Medicine Tumors Of The Hematopoietic And Lymphoid Tissues Acute Myeloid Leukemia Biotechnology Clinical Medicine Immune System Immunology Life Sciences Blastoma CD19 Cancer Treatment Chronic Lymphocytic Leukemia Glioblastoma Health Sciences Immunotherapies Immunotherapy Lymphocytic Leukemia
        Hematologic Malignancies

        Hematologic malignancies are cancers of the blood, bone marrow, and lymphatic system. These cancers can affect the production and function of blood cells, leading to a variety of symptoms and complications. Common types of hematologic malignancies include leukemia, lymphoma, and multiple myeloma. Treatment for hematologic malignancies may include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy.

        Browse All Tags